Keyphrases
Mesenchymal Stem Cells
100%
Immunomodulatory Effect
100%
Receptor Activation
100%
Experimental Autoimmune Encephalomyelitis
100%
Toll-like
100%
Polyinosinic-polycytidylic Acid
50%
T Helper 17 (Th17)
33%
Lipopolysaccharide
33%
T Cell Proliferation
16%
Autoimmune Disease
8%
Cell-based
8%
Lymphocytes
8%
Therapeutic Effect
8%
Inflammatory Cytokines
8%
Tumor-draining Lymph Nodes
8%
Human Mesenchymal Stem Cells (hMSCs)
8%
Nitric Oxide
8%
Immunomodulatory Properties
8%
Flow Cytometry
8%
C57BL
8%
Immunomodulatory Activity
8%
Treg Differentiation
8%
Treg
8%
Euthanized
8%
Th1 Cells
8%
Clinical Score
8%
Th17 Cell Differentiation
8%
Toll-like Receptor 4 (TLR4)
8%
Toll-like Receptor 3 (TLR3)
8%
CD3+ T Cells
8%
CD3+
8%
Immunosuppressive Ability
8%
Intraperitoneal Injection
8%
Intraperitoneal Administration
8%
Blind Analysis
8%
In Vitro Activation
8%
MOG35-55
8%
Immunosuppressive Factors
8%
Th1 Differentiation
8%
Cytokine IL-6
8%
Pharmacology, Toxicology and Pharmaceutical Science
Polyinosinic Polycytidylic Acid
100%
Experimental Autoimmune Encephalomyelitis
100%
Toll Like Receptor
100%
Lipopolysaccharide
66%
Immunosuppressive Agent
50%
CD3 Antigen
33%
Cytokine
16%
Autoimmune Disease
16%
Interleukin 6
16%
Flow Cytometry
16%
Therapeutic Effect
16%
Nitric Oxide
16%
Toll Like Receptor 4
16%
Toll Like Receptor 3
16%
Intraperitoneal Injection
16%
Immunology and Microbiology
Mesenchymal Stem Cell
100%
Experimental Autoimmune Encephalomyelitis
100%
Toll-Like Receptor
100%
Polyinosinic:polycytidylic Acid
50%
Immunosuppressive Drug
25%
Regulatory T Cell
16%
T Cell Proliferation
16%
CD3 Antigen
16%
Autoimmune Disease
8%
Secretion (Process)
8%
T Cell
8%
Proinflammatory Cytokine
8%
Body Weight
8%
Lymph Node
8%
Interleukin 6
8%
Th1 Cell
8%
Th17 Cell
8%
Bone Marrow Derived Mesenchymal Stem Cell
8%
TLR4
8%
TLR3
8%
Lymphocyte
8%